A randomized phase IIB open label study of Nivolumab in combination with Ipilimumab versus Bevacizumab in adult objects with recurrent glioblastoma.
Phase III trial on concurrent and adjuvant temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON intergroup trial.
- Study Phase III
- Selection criteria
A randomized phase II clinical trial on axitinib for the treatment of patients with recurrent glioblastoma.